Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
CPE CONSULTANTS, LLC
 

USP 800 Controlling Hazardous Drugs Excreted by the Patient - Pharmacy Technician


In December 2019 the adoption of United States Pharmacopeia (USP) 800, in conjunction with other existing legal and regulatory standards, will require providers of certain cytotoxic cancer treatments to provide off site collection systems for waste from patients that may contain hazardous materials or their metabolites in order to ensure that they are properly handled and disposed of in the same manner as the parent compound. This course gives the history of why these regulations were put in place, who is responsible, and how to solve this problem in a safe compliant and cost-effective standard of care. We discuss how patients undergoing live saving treatments can protect their families, caregivers and the environment from the cytotoxic chemotherapy drugs as they exit the body.y.

Fee

$5.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacist
  • Pharmacy Technician

Accreditation(s)

CPE Consultants, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education
Accreditation Council for Pharmacy Education
 

Support/Credits

This home study activity was made possible through an educational grant provided by Shepard Medical Products

 

 

 

Objectives

  • Explain what Hazardous Drug Human Waste (HDHW) is
  • Identify HDHW contained in Human waste
  • List agencies that regulate HDHW
  • Describe limitations on Malpractice and Product Liability Insurance Policies
  • Describe collection and disposal methods

Activity Number

0864-9999-18-053-H04-T

Release Date: Jul 1, 2018
Credit Expiration Date: Jul 1, 2021

Fee

$5.00